Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study (Q44017895)

29 November 2017

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study (English)

1 reference

29 November 2017

0 references

1 reference

1 reference

5

1 reference

29 November 2017

6

Nicholas J Wareham

1 reference

29 November 2017

Manjinder S Sandhu

1

1 reference

29 November 2017

Adrian H Heald

series ordinal

2

1 reference

29 November 2017

J Martin Gibson

series ordinal

3

1 reference

29 November 2017

J Kennedy Cruickshank

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

359

1 reference

29 November 2017

1740-1745

1 reference

29 November 2017

9319

1 reference

Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Insulin-like growth factor binding protein-1: recent findings and new directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Fasting proinsulin concentrations predict the development of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Treatment of type A insulin resistance with insulin-like growth factor-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Epidemiology of the insulin-like growth factor system in three ethnic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

Insulin-like growth factor binding protein-1 induces insulin release in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908655-5

7 January 2021

10.1016/S0140-6736(02)08655-5

Identifiers

DOI

1 reference

29 November 2017

1 reference